Clinical status of direct thrombin inhibitors

被引：9

作者：

Agnelli, G ^{[1
]}

Sonaglia, F ^{[1
]}

机构：

[1] Univ Perugia, Ist Med Interna & Med Vascolare, I-06126 Perugia, Italy

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 1999年 / 31卷 / 02期

关键词：

D O I：

10.1016/S1040-8428(99)00006-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：97 / 117

页数：21

共 156 条

[1]

AGNELLI G, 1992, THROMB HAEMOSTASIS, V67, P203

[2]

AGNELLI G, 1992, BLOOD, V80, P960

[3]

AGNELLI G, 1991, THROMB HAEMOSTASIS, V66, P592

[4]

AGNELLI G, 1990, THROMB HAEMOSTASIS, V63, P204

[5]

Alexander JH, 1996, CIRCULATION, V94, P1143

[6] Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis [J].

Alving, BM ;

Krishnamurti, C .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (06) :569-574

[7] Thrombin inhibition with inogatran for unstable angina pectoris: Evidence for reactivated ischaemia after cessation of short-term treatment [J].

Andersen, K ;

Dellborg, M ;

Emanuelsson, H ;

Grip, L ;

Swedberg, K .

CORONARY ARTERY DISEASE, 1996, 7 (09) :673-681

[8]

[Anonymous], 1994, Circulation, V90, P1631

[9] HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL [J].

ANTMAN, EM .

CIRCULATION, 1994, 90 (04) :1624-1630

[10] Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial [J].

Antman, EM .

CIRCULATION, 1996, 94 (05) :911-921

← 1 2 3 4 5 6 7 8 9 10 →